Cost-effectiveness analysis of ibrutinib in patients with...

Journal of Market Access & Health Policy 2017 / 01 Vol. 5; Iss. 1

Cost-effectiveness analysis of ibrutinib in patients with Waldenström macroglobulinemia in Italy

Aiello, Andrea, D’Ausilio, Anna, Lo Muto, Roberta, Randon, Francesca, Laurenti, Luca
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
5
Language:
english
Journal:
Journal of Market Access & Health Policy
DOI:
10.1080/20016689.2017.1393308
Date:
January, 2017
File:
PDF, 1.06 MB
english, 2017
Conversion to is in progress
Conversion to is failed